当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20207
编号:13499186
腺苷脱氨酶水平与类风湿关节炎关系的荟萃分析(5)
http://www.100md.com 2020年3月5日 《中国医药导报》 20207
     [21] Hitoglou S,Hatzistilianou M,Gougoustamou D,et al. Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus [J]. Clin Rheumatol,2001,20(6):411-416.

    [22] Yuksel H,Ako■lu TF. Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis,osteoarthritis,and reactive arthritis [J]. Ann Rheum Dis,1988,47(6):492-495.

    [23] Yuji N,Koshiba M,Nakazawa T,et al. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts [J]. Arthritis Rheum,2003,48(3):668-674.

    [24] Osmani AM,Sayeed D,Ali GM,et al. Study of serum adenosine deaminase and alkaline phosphatase in rheumatoid arthritis [J]. Evol of Med and Dent Sci,2015,49(4):312-318.

    [25] Gautam N,Archana J,Kumar R,et al. Serum total adenosine deaminase activity in Nepalese patients with Rheumatoid Arthritis [J]. Asian of Med Sci,2013,4(2):30-35.

    [26] Jasminka MN,Jasenka LM,Milada SN,et al. Citrullinated peptide antibodies,adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis [J]. Med Bio,2008,27(3):383-388.

    [27] da Silva J,Passos DF,Bernardes VM,et al. ATP and adenosine:Role in the immunopathogenesis of rheumatoid arthritis [J]. Immunol Lett,2019,214:55-64.

    (收稿日期:2019-09-03 本文編辑:刘明玉), http://www.100md.com(蔡昕添 朱晴 吴婷)
上一页1 2 3 4 5